Abstract:Natural killer (NK) cells represent an important subpopulation of lymphocytes that are distributed throughout the body. The development of NK cells primarily occurs in the bone marrow during adult life, involving several putative intermediate stages that finally result in functional maturation. At steady state, NK cell egress from the bone marrow to various peripheral areas is controlled by a network of adhesion molecules, including integrins, selectins, and chemokine receptors and their corresponding ligands. NK cells at different developmental stages express distinct repertoire of adhesion molecules and can therefore be recruited to different sites of the body, including lymphoid and non-lymphoid tissues, and NK cells undergo further differentiation dirven by local microenvironmental signals, resulting in unique tissue-specific NK cells. Through their abilities of cytotoxicity and cytokine production, NK cells not only play key roles in the innate immune system, but also participate in shaping adaptive immune responses. On the basis of their heterogeneity in phenotype, function, and tissue distribution, NK cells can be further subdivided into distinct subsets. Under pathological conditions, such as in autoimmune, inflammatory, and infectious diseases, as local microenvironment changes, NK cell subsets would redistribute between tissues and organs and rapidly accumulate at the local pathological sites to exert their effector functions. Here, we describe the development and tissue distribution of NK cell subsets in mice and humans. We focus on the trafficking of NK cell subsets within the bone marrow and emigration into periphery at steady state, and molecular mechanisms involved in their trafficking in autoimmune diseases.

Molecular mechanisms of NK cell development and diseases associated with functional compromise of NK cells

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies

The Reciprocal Interactions between Natural Killer Cells and Dendritic Cells

NK cell-based cancer immunotherapy: from basic biology to clinical development

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization

Regulation of Mouse NK Cell Development and Function by Cytokines

NK Cell Dysfunction and Checkpoint Immunotherapy

Research progress on negative regulation of adaptive immune response by NK cells

“Multi-Omics” Analyses of the Development and Function of Natural Killer Cells

Developmental and Functional Control of Natural Killer Cells by Cytokines

NK Cell Trafficking in Health and Autoimmunity:A Comprehensive Review

Current status and future perspective of natural killer cell therapy for cancer.

Advancements in the Study of the Immune Molecule NKp46 in Immune System-related Diseases

Research Progress on NK Cell Receptors and Their Signaling Pathways

Genomic Expression Profiling of NK Cells in Health and Disease.

Control of NK Cell Activation by Immune Checkpoint Molecules

Progress in NK Cell-Based Immunotherapy of Tumor

Immune Checkpoint Molecules in Natural Killer Cells As Potential Targets for Cancer Immunotherapy.

Technical advances in NK cell-based cellular immunotherapy

NK cells regulating T cell responses: mechanisms and outcome